Avalyn Pharma Inc. Common Stock

NASDAQ:AVLN

Medical - Pharmaceuticals

Healthcare
$27.69 +1.77%

+$0.52 today

Market cap
$1.23B
Beta
0.00
52W Low $24.15High $32.23

Volume 0.40M

Average 0.51M

AVLN Long-term Investments

Investments the company intends to hold for more than a year.

No reported Long-term Investments figures are available to summarize.

Long-term Investments history

Currency unavailable · from the balance sheet

No Long-term Investments data reported for this period type.

Long-term Investments vs competitors

How AVLN compares with its peers on the latest reported figures

AVLN Competitors
Long-term Investments for AVLN and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
GYREGyre Therapeutics, Inc.Mar 2026$31.02M USD+45.2%—19.1%
MNKDMannKind CorporationMar 2026$747K USD-95.5%+36.7%0.1%
INSMInsmed IncorporatedJun 2026$0 USD——0.0%
VCREVicore Pharma Holding ABJun 2026SEK 0 SEK——0.0%
AVLNAvalyn Pharma Inc. Common Stock—— ———
Peer median (excluding AVLN) —-25.2%+36.7%0.1%

Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Avalyn Pharma Inc. Common Stock

NASDAQ:AVLN

Intrinsic Alpha fair value

Locked

Current Price

$27.69

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.